Serum brain-derived neurotrophic factor concentration is different between autism spectrum disorders and intellectual disability children and adolescents
- 4 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 170, 355-360
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Biomarkers in autism spectrum disorder: the old and the newPsychopharmacology, 2013
- In search of biomarkers for autism: scientific, social and ethical challengesNature Reviews Neuroscience, 2011
- Matrix Metalloproteinase-9 Contributes to Kindled Seizure Development in Pentylenetetrazole-Treated Mice by Converting Pro-BDNF to Mature BDNF in the HippocampusThe Journal of Neuroscience, 2011
- Vulnerability to Depression: From Brain Neuroplasticity to Identification of BiomarkersJournal of Neuroscience, 2011
- The role of neurotrophic factors in autismMolecular Psychiatry, 2010
- New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS FunctionThe Journal of Neuroscience, 2009
- Pro-BDNF–induced synaptic depression and retraction at developing neuromuscular synapsesJournal of Cell Biology, 2009
- Control of extracellular cleavage of ProBDNF by high frequency neuronal activityProceedings of the National Academy of Sciences, 2009
- Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress?Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Distribution and localization of pro‐brain‐derived neurotrophic factor‐like immunoreactivity in the peripheral and central nervous system of the adult ratJournal of Neurochemistry, 2004